Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mielke

Showing results (181-190 of 602) with videos related to

Pageof 61
Sort By:
Journal of Neurovirology|October 25, 2017
Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trialNed Sacktor, Richard L Skolasky, Richard Moxley, et al.
Deutsche Medizinische Wochenschrift (1946)|May 13, 1988
[Pulmonary complications in acquired immunodeficiency syndrome. Results of a prospective study]G Höffken, H Lode, T Dissmann, et al.
International Journal of Geriatric Psychiatry|April 28, 2012
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's diseaseDaniel C Parker, Michelle M Mielke, Qilu Yu, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2021
Peripheral Markers of Neurovascular Unit Integrity and Amyloid-β in the Brains of Menopausal WomenMuthuvel Jayachandran, Virginia M Miller, Brian D Lahr, et al.
Journal of Alzheimer'S Disease : JAD|December 31, 2016
The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of AgingMichelle M Mielke, Norman J Haughey, Dingfen Han, et al.
Journal of Racial and Ethnic Health Disparities|February 28, 2025
Diabetes and Hypertension at Midlife Predict Increases in Biomarkers of Dementia Among Black AmericansRonald L Simons, Mei Ling Ong, Man-Kit Lei, et al.
Neurology|January 6, 2022
Sex Differences in the Association Between Midlife Cardiovascular Conditions or Risk Factors With Midlife Cognitive DeclineNan Huo, Prashanthi Vemuri, Jonathan Graff-Radford, et al.
Advanced Drug Delivery Reviews|May 4, 2020
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methodsDaan van Kruining, Qian Luo, Gerhild van Echten-Deckert, et al.
Journal of General Internal Medicine|March 19, 2025
Central Nervous System-Active Medication Use in Older Adults With and Without Dementia-A Retrospective Cohort StudyNafisseh S Warner, Holly K Van Houten, Ericka E Tung, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2016
Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of AgingAlexandra M V Wennberg, Deborah Gustafson, Clinton E Hagen, et al.
Pageof 61

Showing results (181-190 of 602) with videos related to

Sort By:
Pageof 61
Journal of Neurovirology|October 25, 2017
Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trialNed Sacktor, Richard L Skolasky, Richard Moxley, et al.
Deutsche Medizinische Wochenschrift (1946)|May 13, 1988
[Pulmonary complications in acquired immunodeficiency syndrome. Results of a prospective study]G Höffken, H Lode, T Dissmann, et al.
International Journal of Geriatric Psychiatry|April 28, 2012
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's diseaseDaniel C Parker, Michelle M Mielke, Qilu Yu, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2021
Peripheral Markers of Neurovascular Unit Integrity and Amyloid-β in the Brains of Menopausal WomenMuthuvel Jayachandran, Virginia M Miller, Brian D Lahr, et al.
Journal of Alzheimer'S Disease : JAD|December 31, 2016
The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of AgingMichelle M Mielke, Norman J Haughey, Dingfen Han, et al.
Journal of Racial and Ethnic Health Disparities|February 28, 2025
Diabetes and Hypertension at Midlife Predict Increases in Biomarkers of Dementia Among Black AmericansRonald L Simons, Mei Ling Ong, Man-Kit Lei, et al.
Neurology|January 6, 2022
Sex Differences in the Association Between Midlife Cardiovascular Conditions or Risk Factors With Midlife Cognitive DeclineNan Huo, Prashanthi Vemuri, Jonathan Graff-Radford, et al.
Advanced Drug Delivery Reviews|May 4, 2020
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methodsDaan van Kruining, Qian Luo, Gerhild van Echten-Deckert, et al.
Journal of General Internal Medicine|March 19, 2025
Central Nervous System-Active Medication Use in Older Adults With and Without Dementia-A Retrospective Cohort StudyNafisseh S Warner, Holly K Van Houten, Ericka E Tung, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2016
Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of AgingAlexandra M V Wennberg, Deborah Gustafson, Clinton E Hagen, et al.
Pageof 61